Publications
December 18, 2024
New ADAI Articles: Pharmacy Staff and Naloxone & PReP Use by MSM Who Use Substances
Two new papers by ADAI researchers and colleagues are now available! Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains. Green TC, Silcox J, Bolivar D, Gray M, Floyd AS, et al. J Amer Pharm Assoc 2024;64(1):71-78. [subscription access] This paper…
November 14, 2024
New from CERP Director Beatriz Carlini: Report & Recommendations of the High Potency Cannabis Think Tank to the State of California
ADAI’s Cannabis Education & Research Program Director Beatriz Carlini, PhD, MPH is one of the co-authors of a new report: “Report and Recommendations of the High Potency Cannabis Think Tank to the State of California.” This report was prepared by a committee of scientists (including Dr. Carlini) and medical experts convened by the California Department…
September 20, 2024
New ADAI Research: Community-Based Medications First for Opioid Use Disorder
Citation: Banta-Green CJ, Owens MD, Williams JR, Floyd AS, Williams-Gilbert W, Kingston S. Community-based medications first for opioid use disorder – Care utilization and mortality outcomes. Substance Abuse and Rehabilitation 2024;15:173-183. The most effective and evidence-based treatments for opioid use disorder (OUD) are medications for OUD (MOUD) like buprenorphine, methadone, and extended-release injectable naltrexone. However,…
September 17, 2024
WA State Drug Brief: BTMPS: New Substance Found in Community Drug Checking Samples
In June 2024, a new substance, Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS), was detected in the unregulated drug supply nationally in community drug testing programs, most commonly in products sold as and containing fentanyl. BTMPS is an industrial chemical with no approved use in humans. The effects of the substance and why it might be in the drug…
September 16, 2024
New ADAI Publication: Substance Use Disorder Training for WA State Basic Law Enforcement Academy
Citation: Owens MD, et al. Development and exploratory evaluation of substance use and substance use disorder training for the Washington State Basic Law Enforcement Academy. Policing 2024;18:paae091. In 2021, Washington State passed a law requiring all new law enforcement officers to get training on substance use disorder (SUD), with a goal of improving conflict resolution…
September 9, 2024
New Resource: Health Engagement Programs Resource Kit
Health engagement programs are a newer model of care for people who use drugs. The model featured in this resource kit, developed by the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER), uses a care team or “health support team” of a prescriber, nurse care manager, care navigator, and a mental health coordinator, all working…
July 9, 2024
New ADAI Report: Language Matters: Cannabis & Tobacco Use Among Youth of Diverse Racial/Ethnic Backgrounds
Citation: Language Matters: Cannabis and Tobacco Use Among Youth of Diverse Racial/Ethnic Backgrounds. Carlini BH, Harwick RH, Williams JR. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, July 2024. Previous studies have highlighted the importance of acculturation — when someone adopts the values and…
June 11, 2024
New ADAI Publications on Cannabis and Opioid Policy
Several ADAI researchers have some new publications out recently related to cannabis and opioid policy: State Requirements for Non-Medical Cannabis “Budtenders” Beatriz Carlini, PhD, MPH, Research Associate Professor and Director of ADAI’s Cannabis Education & Research Program, is coauthor of a new paper on State requirements for non-medical US cannabis retail personnel (LoParco C, et…
May 6, 2024
Two New Reports from ADAI CEDEER: Kratom and Contingency Management
ADAI’s Center for Community-Engaged Drug Education, Epidemiology, and Research (CEDEER) has two new reports out this week! Kratom: What do we know about its use, safety, and overdose risk? Mandy Sladky, MSN, RN, CARN, and Caleb Banta-Green, PhD, MPH, MSW Kratom is a psychoactive substance made from the leaves of the Mitragyna speciosa tree that…
April 22, 2024
Results from the 2023 WA State Syringe Services Program Health Survey
Involving people who use drugs in meaningful ways to design and deliver the services offered to them is important. People who use drugs have clear preferences, insights, and innovative ideas for service models and are eager to share their perspectives when given genuine opportunities for input and involvement. To capture some of that vital information,…
Next page
